Solving the puzzle of fibrosis resolution in alcohol-associated liver disease: An insight from KDM5 demethylases and LXR activation

被引：0
|
作者：
Ma, Jing [1 ,3 ]
Liangpunsakul, Suthat [1 ,2 ]
机构：
[1] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN USA
[2] Richard L Roudebush Vet Adm Med Ctr, Med Serv, Indianapolis, IN USA
[3] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, 702 Rotary Circle, Indianapolis, IN 46202 USA
来源：
HEPATOLOGY | 2024年 / 80卷 / 01期
关键词：
STELLATE CELLS ACTIVATION; INVERSE AGONIST; ABSTINENCE; PROGNOSIS; MODEL;
D O I：
10.1097/HEP.0000000000000781
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：14 / 17
页数：4
相关论文
共 50 条
  • [11] Recent insight into the role of macrophage in alcohol-associated liver disease: a mini-review
    Sun, Jialiang
    Zhao, Peiliang
    Shi, Ying
    Li, Yanan
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [12] COGNITIVE INTERVIEWING OF EXPERTS AND PATIENTS TO DEVELOP AN ALCOHOL INSIGHT SCALE FOR PATIENTS WITH ALCOHOL-ASSOCIATED LIVER DISEASE
    Gill, Victoria
    Patel, Shivali
    Mellinger, Jessica
    Winder, Gerald Scott
    HEPATOLOGY, 2024, 80 : S1093 - S1093
  • [13] Dually Active Polycation/miRNA Nanoparticles for the Treatment of Fibrosis in Alcohol-Associated Liver Disease
    Zhang, Chuhan
    Hang, Yu
    Tang, Weimin
    Sil, Diptesh
    Jensen-Smith, Heather C.
    Bennett, Robert G.
    McVicker, Benita L.
    Oupicky, David
    PHARMACEUTICS, 2022, 14 (03)
  • [14] Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease
    Koizumi, Aritoshi
    Kaji, Kosuke
    Nishimura, Norihisa
    Asada, Shohei
    Matsuda, Takuya
    Tanaka, Misako
    Yorioka, Nobuyuki
    Tsuji, Yuki
    Kitagawa, Koh
    Sato, Shinya
    Namisaki, Tadashi
    Akahane, Takemi
    Yoshiji, Hitoshi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (28)
  • [15] Elafibranor: A promising therapeutic approach for liver fibrosis and gut barrier dysfunction in alcohol-associated liver disease
    Cheng, Chun-Han
    Hao, Wen-Rui
    Cheng, Tzu-Hurng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2025, 31 (03)
  • [16] Editorial: Alcohol-associated liver disease-From pathogenesis to treatment
    Kharbanda, Kusum K.
    Singal, Ashwani K.
    Mueller, Sebastian
    Osna, Natalia A.
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [17] Fungal signature differentiates alcohol-associated liver disease from nonalcoholic fatty liver disease
    Viebahn, Greta
    Hartmann, Phillipp
    Lang, Sonja
    Demir, Muenevver
    Zhang, Xinlian
    Fouts, Derrick E.
    Starkel, Peter
    Schnabl, Bernd
    GUT MICROBES, 2024, 16 (01)
  • [18] GLUTAMATE VESICLES DRIVE ALCOHOL-ASSOCIATED LIVER DISEASE THROUGH KUPFFER CELL ACTIVATION
    Yang, Keungmo
    Ryu, Tom
    Shim, Young-Ri
    Kim, Hee-Hoon
    Kim, Kyurae
    Choi, Sung Eun
    Kim, MinJeong
    Woo, Chaerin
    Chung, Katherine Po Sin
    Hong, Song Hwa
    Kim, Won
    Soo, Eun Hyuk
    Jeong, Won-Il
    HEPATOLOGY, 2022, 76 : S948 - S949
  • [19] The association between alcohol consumption and cardiometabolic factors and liver fibrosis in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated liver disease
    Sogabe, Masahiro
    Okahisa, Toshiya
    Kagawa, Miwako
    Kashihara, Takanori
    Shinomiya, Ryo
    Miyake, Takanori
    Kawaguchi, Tomoyuki
    Yokoyama, Reiko
    Kagemoto, Kaizo
    Kida, Yoshifumi
    Okada, Yasuyuki
    Tomonari, Tetsu
    Kawano, Yutaka
    Sato, Yasushi
    Nakasono, Masahiko
    Takayama, Tetsuji
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (11-12) : 1587 - 1598
  • [20] Outcomes from early liver transplantation for alcohol-associated liver disease at a single center
    Meinders, A.
    Connor, A. A.
    Patel, K.
    Ontiveros, J.
    Nottage, D. L.
    Brombosz, E. W.
    Moore, L. W.
    Simon, C. J.
    Cheah, Y. L.
    Hobeika, M.
    Mobley, C. M.
    Saharia, A.
    Basra, T.
    Kodali, S.
    Victor, D. W., III
    Gaber, A. O.
    Ghobrial, R. M.
    LIVER TRANSPLANTATION, 2024, 30 : 52 - 52
12345